Abevmy 100 mg Injection
Abevmy 100 mg Injection Abevmy 100 mg/4 mL is a bevacizumab-containing biological medicine used in the treatment of several advanced or metastatic cancers. Bevacizumab is a recombinant humanized monoclonal antibody that targets vascular endothelial growth factor (VEGF). By reducing VEGF activity, it limits the development of new blood vessels that tumors need for continued growth and spread.
| Brand | Abevmy |
| Storage Temperature | 2°C–8°C |
| Prescription Needed | Yes |
| Composition | Bevacizumab |
| Strength | 100 mg/4 mL |
| Form | Concentrate for solution for infusion |
| Pack Size | 1 vial × 4 mL |
| Packaging | Vial |
| Country of Origin | Made In India |
| Manufacturer | Mylan Pharmaceuticals Pvt. Ltd. |
Abevmy 100 mg Injection
Abevmy 100 mg Injection Abevmy 100 mg/4 mL is a bevacizumab-containing biological medicine used in the treatment of several advanced or metastatic cancers. Bevacizumab is a recombinant humanized monoclonal antibody that targets vascular endothelial growth factor (VEGF). By reducing VEGF activity, it limits the development of new blood vessels that tumors need for continued growth and spread.
